{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:24:57Z","timestamp":1783700697842,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP2fk0108123"],"award-info":[{"award-number":["JP2fk0108123"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.antiviral.2022.105487","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T15:26:45Z","timestamp":1671722805000},"page":"105487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Interferon-induced restriction of Chikungunya virus infection"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3554-0755","authenticated-orcid":false,"given":"Youichi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105487_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.aivir.2021.07.003","article-title":"Alphavirus RNA replication in vertebrate cells","volume":"111","author":"Ahola","year":"2021","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2022.105487_bib2","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1128\/JVI.00541-12","article-title":"Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II","volume":"86","author":"Akhrymuk","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib3","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.1074\/jbc.M112.438515","article-title":"Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry","volume":"288","author":"Anafu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2022.105487_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell's first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.antiviral.2022.105487_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011479","article-title":"Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments","volume":"5","author":"Bernard","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105487_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/517537","article-title":"Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients","volume":"44","author":"Borgherini","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105487_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virol.2008.10.021","article-title":"The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus","volume":"384","author":"Brehin","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105487_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105487_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1537-2995.2008.01646.x","article-title":"Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007","volume":"48","author":"Brouard","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.antiviral.2022.105487_bib11","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coviro.2017.11.006","article-title":"Innate immune control of alphavirus infection","volume":"28","author":"Carpentier","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1995-7645(13)60108-X","article-title":"Cytokine levels in patients with chikungunya virus infection","volume":"6","author":"Chirathaworn","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.antiviral.2022.105487_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00841-19","article-title":"Distinct roles of interferon alpha and beta in controlling chikungunya virus replication and modulating neutrophil-mediated inflammation","volume":"94","author":"Cook","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib15","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105487_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2015.07.002","article-title":"Chikungunya virus pathogenesis: from bedside to bench","volume":"121","author":"Couderc","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105487_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri3344","article-title":"The broad-spectrum antiviral functions of IFIT and IFITM proteins","volume":"13","author":"Diamond","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2022.105487_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080723","article-title":"Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model","volume":"8","author":"Everitt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105487_bib19","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1073\/pnas.1705402114","article-title":"Structural studies of viperin, an antiviral radical SAM enzyme","volume":"114","author":"Fenwick","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2022.105487_bib20","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000909","article-title":"Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction","volume":"4","author":"Franz","year":"2021","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.antiviral.2022.105487_bib21","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1128\/JVI.00949-10","article-title":"Chikungunya virus nonstructural protein 2 inhibits type I\/II interferon-stimulated JAK-STAT signaling","volume":"84","author":"Fros","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib22","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1371\/journal.pmed.0050060","article-title":"Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion","volume":"5","author":"Gerardin","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2022.105487_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/200050a0","article-title":"Effect of actinomycin D on interferon production by 'active' and 'inactive' chikungunya virus in chick cells","volume":"200","author":"Gifford","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105487_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-018-0238-4","article-title":"A naturally occurring antiviral ribonucleotide encoded by the human genome","volume":"558","author":"Gizzi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105487_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3201\/eid2104.141723","article-title":"Reappearance of chikungunya, formerly called dengue, in the americas","volume":"21","author":"Halstead","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib26","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.4049\/jimmunol.0904181","article-title":"Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response","volume":"184","author":"Her","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2022.105487_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbrc.2014.04.081","article-title":"Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication","volume":"448","author":"Hishiki","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2022.105487_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105487_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virol.2013.01.010","article-title":"BST-2\/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1)","volume":"438","author":"Jones","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105487_bib30","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3201\/eid1212.060710","article-title":"Chikungunya disease outbreak, reunion island","volume":"12","author":"Josseran","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib31","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1371\/journal.pntd.0001279","article-title":"Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity","volume":"5","author":"Kelvin","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/v2040796","article-title":"Alphavirus entry and membrane fusion","volume":"2","author":"Kielian","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105487_bib33","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.4049\/jimmunol.1000098","article-title":"Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A","volume":"185","author":"Kim","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2022.105487_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-virology-091919-102021","article-title":"New insights into chikungunya virus infection and pathogenesis","volume":"8","author":"Kril","year":"2021","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.antiviral.2022.105487_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virusres.2019.01.014","article-title":"A key anti-viral protein, RSAD2\/VIPERIN, restricts the release of measles virus from infected cells","volume":"263","author":"Kurokawa","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2022.105487_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105487_bib37","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1097\/CCM.0b013e318183f2d2","article-title":"Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006","volume":"36","author":"Lemant","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2022.105487_bib38","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1073\/pnas.0607038104","article-title":"IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses","volume":"104","author":"Lenschow","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2022.105487_bib39","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib40","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1099\/vir.0.068643-0","article-title":"Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection","volume":"95","author":"Mahauad-Fernandez","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3201\/eid1403.070720","article-title":"Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India","volume":"14","author":"Mavalankar","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1473-3099(07)70091-9","article-title":"Chikungunya epidemic in India: a major public-health disaster","volume":"7","author":"Mavalankar","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.39027","article-title":"Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis","volume":"67","author":"Miner","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.antiviral.2022.105487_bib44","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1128\/JVI.03382-12","article-title":"IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus","volume":"87","author":"Mudhasani","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154366","article-title":"Antiviral role of IFITM proteins in african swine fever virus infection","volume":"11","author":"Munoz-Moreno","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105487_bib46","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M115.657346","article-title":"The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry","volume":"290","author":"Narayana","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2022.105487_bib47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2012-01-407395","article-title":"HIV-1 infection of human macrophages directly induces viperin which inhibits viral production","volume":"120","author":"Nasr","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2022.105487_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105487_bib49","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/v7042147","article-title":"BST2\/tetherin inhibition of alphavirus exit","volume":"7","author":"Ooi","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105487_bib50","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1210.060610","article-title":"Novel chikungunya virus variant in travelers returning from Indian Ocean islands","volume":"12","author":"Parola","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib51","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.00655-16","article-title":"The interferon-stimulated gene IFITM3 restricts infection and pathogenesis of arthritogenic and encephalitic alphaviruses","volume":"90","author":"Poddar","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.07.008","article-title":"Human mAbs broadly protect against arthritogenic alphaviruses by recognizing conserved elements of the Mxra8 receptor-binding site","volume":"28","author":"Powell","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105487_bib53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/107999099313992","article-title":"The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties","volume":"19","author":"Rebouillat","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2022.105487_bib54","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jmv.23875","article-title":"Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine\/chemokine levels during acute Chikungunya virus infection","volume":"86","author":"Reddy","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-virology-011720-095930","article-title":"Viperin reveals its true function","volume":"7","author":"Rivera-Serrano","year":"2020","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.antiviral.2022.105487_bib56","doi-asserted-by":"crossref","first-page":"13036","DOI":"10.1128\/JVI.01194-10","article-title":"The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication","volume":"84","author":"Saikia","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib57","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","article-title":"The IFITMs inhibit zika virus replication","volume":"15","author":"Savidis","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2022.105487_bib58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.20090851","article-title":"Type I IFN controls chikungunya virus via its action on nonhematopoietic cells","volume":"207","author":"Schilte","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2022.105487_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2022.105487_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/v11111078","article-title":"Cellular attachment and entry factors for chikungunya virus","volume":"11","author":"Schnierle","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105487_bib61","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: what do they all do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.antiviral.2022.105487_bib62","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105487_bib63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of chikungunya virus","volume":"8","author":"Schwartz","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105487_bib64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105487_bib65","doi-asserted-by":"crossref","first-page":"12720","DOI":"10.1128\/JVI.01471-07","article-title":"Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response","volume":"81","author":"Silverman","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007800","article-title":"Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study","volume":"4","author":"Soumahoro","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105487_bib67","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1371\/journal.ppat.0030089","article-title":"Characterization of reemerging chikungunya virus","volume":"3","author":"Sourisseau","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105487_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007603","article-title":"Prospective study of Chikungunya virus acute infection in the Island of La Reunion during the 2005-2006 outbreak","volume":"4","author":"Staikowsky","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105487_bib69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105487_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2009.06.027","article-title":"Systemic involvements and fatalities during Chikungunya epidemic in India, 2006","volume":"46","author":"Tandale","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib71","article-title":"Viperin inhibits rabies virus replication via reduced cholesterol and sphingomyelin and is regulated upstream by TLR4","volume":"6","author":"Tang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105487_bib72","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI63120","article-title":"Viperin restricts chikungunya virus replication and pathology","volume":"122","author":"Teng","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2022.105487_bib73","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/infdis\/jiv049","article-title":"A systematic meta-analysis of immune signatures in patients with acute chikungunya virus infection","volume":"211","author":"Teng","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105487_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.1202177","article-title":"A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2022.105487_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105487_bib76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","article-title":"The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein","volume":"3","author":"Van Damme","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105487_bib77","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1371\/journal.pone.0001168","article-title":"Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus","volume":"2","author":"Vazeille","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105487_bib78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fimmu.2014.00094","article-title":"IFITs: emerging roles as key anti-viral proteins","volume":"5","author":"Vladimer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2022.105487_bib79","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.01603-09","article-title":"Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates","volume":"84","author":"Volk","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105487_bib80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105487_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105487_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008999","article-title":"Chikungunya virus antagonizes cGAS-STING mediated type-I interferon responses by degrading cGAS","volume":"16","author":"Webb","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105487_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002322","article-title":"ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation","volume":"7","author":"Werneke","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105487_bib84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1742-4690-8-95","article-title":"Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag","volume":"8","author":"Woods","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.antiviral.2022.105487_bib85","article-title":"ISGylation in innate antiviral immunity and pathogen defense responses: a review","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.antiviral.2022.105487_bib86","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","article-title":"Mxra8 is a receptor for multiple arthritogenic alphaviruses","volume":"557","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105487_bib87","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1073\/pnas.0909144107","article-title":"ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells","volume":"107","author":"Zhao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2022.105487_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.979091","article-title":"Multi-functional BST2\/tetherin against HIV-1, other viruses and LINE-1","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422200256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422200256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:39:03Z","timestamp":1759063143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635422200256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":88,"alternative-id":["S016635422200256X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105487","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-induced restriction of Chikungunya virus infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105487"}}